Cardiac Rehabilitation and Low Frequency Electrical MyoStimulation in Chronic Heart Failure

NCT ID: NCT01408875

Last Updated: 2015-03-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if addition of low frequency electro-myo-stimulation to cardiac rehabilitation is effective to improve exercise capacity and/or muscular strength in chronic heart failure patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In chronic heart failure, low exercise capacity is due, in part, to peripheral muscles abnormalities. Exercise training performed during cardiac rehabilitation improves exercise tolerance measured by cardiopulmonary exercise test. Low frequency electromyostimulation (EMS) was proposed as an alternative to exercise training (ET) in this population.

However, the effectiveness of the combination (EMS +ET) compared with ET alone is not proved. The main objective is to compare exercise capacity judged by peak VO2 after treatment by ET alone versus EMS+ET. The secondary end points are results on sub maximal parameters, muscular resistance, quality of life and effectiveness regarding clinical sub-groups.

This study is a controlled, randomized, multicentric (14 centres) designed to include 90 patients by group in two years period. Inclusion criteria are: CHF patients , NYHA class II to IIIb, with LVEF \< 40% referred to complete a cardiac rehabilitation program.

All the patients benefit from a comprehensive cardiac rehabilitation program including educational program, therapeutical optimisation and exercise training for 20 sessions, 3 to 5 days a week. The group of patients randomized for additional EMS has 20 sessions of 1 hour electrical quadricipital myostimulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rehabilitation and EMS Group

Patient Heart Failure who follows physical training and sessions of electrical quadricipital myostimulation.

Group Type EXPERIMENTAL

Low electrical myostimulation

Intervention Type DEVICE

The group of patients randomized for additional EMS will have 20 sessions of 1 hour electrical quadricipital myostimulation.

Rehabilitation Group only

Patient Heart Failure who follows physical training

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low electrical myostimulation

The group of patients randomized for additional EMS will have 20 sessions of 1 hour electrical quadricipital myostimulation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age from 18 to 75 yo
* stable Chronic Heart Failure (CHF) under "optimal" treatment since at least 1 week
* NYHA functional class II to IIIb
* left ventricular ejection fraction \< 40%
* cardiopulmonary exercise test feasible
* whatever etiology of heart failure
* age of heart failure ≥ 3 months.
* have signed the consent document to participate in the study

Exclusion Criteria

* previous treatment by functional electrical myo stimulation
* recent acute heart failure or inotropic intravenous agents used (\< 10 days)
* recent coronary angioplasty (\< 10 days)
* cardiac surgery \< 1 month
* valvular disease requiring surgical treatment
* uncontrolled hypertension (≥ systolic 180 and/or diastolic 110 mmHg)
* severe respiratory insufficiency (VEMS \< 1000 ml)
* pregnancy
* Automatic implantable defibrillator
* pace-makers : cardiac stimulation dependence or not known
* incapacity to achieve 6 min walk test and/or exercise testing
* absolute contra-indication to exercise test and/or exercise training
* myocarditis or pericarditis
* uncontrolled ventricular arrhythmias
* Obesity (BMI ≥ 35)
* known and documented peripheral myopathy
* participation to another study protocol
* patient incapable of giving consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gulf Estuarine Research Society (GERS)

OTHER

Sponsor Role collaborator

Bourgogne Association of Cardiology

UNKNOWN

Sponsor Role collaborator

Ile-de-France Association of Cardiology

UNKNOWN

Sponsor Role collaborator

French Cardiology Society

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie Christine Iliou, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Corentin Celton

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de réadaptation spécialisé Saint Luc

Abreschviller, , France

Site Status

Polyclinique Bordeaux Nord Aquitaine

Bordeaux, , France

Site Status

Centre Hospitalier de la Côte Fleurie

Cricquebœuf, , France

Site Status

Clinique SSR "Les Rosiers"

Dijon, , France

Site Status

Hôpital Bocage Central

Dijon, , France

Site Status

Hôpital Corentin Celton

Issy-les-Moulineaux, , France

Site Status

Hôpital de Joigny

Joigny, , France

Site Status

Clinique de la Mitterie

Lomme, , France

Site Status

Centre Hospitalier Loire Vendée Ocean

Machecoul, , France

Site Status

Hôpital de jour de soins de suite et de réadaptation Léopold Bellan

Paris, , France

Site Status

Clinique Saint-Yves

Rennes, , France

Site Status

Hôpital Intercommunal Sud Léman Valserine

Saint-Julien-en-Genevois, , France

Site Status

Centre de réadaptation cardiaque Leopold Bellan

Tracy-le-Mont, , France

Site Status

Les Grands Prés

Villeneuve-Saint-Denis, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.